CZ2004997A3 - Nová forma N-(trans-4-isopropylcyklohexylkarbonyl)-D-fenylalaninu - Google Patents

Nová forma N-(trans-4-isopropylcyklohexylkarbonyl)-D-fenylalaninu Download PDF

Info

Publication number
CZ2004997A3
CZ2004997A3 CZ2004997A CZ2004997A CZ2004997A3 CZ 2004997 A3 CZ2004997 A3 CZ 2004997A3 CZ 2004997 A CZ2004997 A CZ 2004997A CZ 2004997 A CZ2004997 A CZ 2004997A CZ 2004997 A3 CZ2004997 A3 CZ 2004997A3
Authority
CZ
Czechia
Prior art keywords
isopropylcyclohexylcarbonyl
phenylalanine
trans
methyl ester
phenylalanine methyl
Prior art date
Application number
CZ2004997A
Other languages
Czech (cs)
English (en)
Inventor
Shanmughasamy Rajamahendra
Chandrashekar Aswathanarayanappa
Tom Thomas Puthiaparampil
Madhavan Sridharan
Sambasivam Ganesh
Original Assignee
Biocon Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Limited filed Critical Biocon Limited
Publication of CZ2004997A3 publication Critical patent/CZ2004997A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ2004997A 2002-04-29 2002-04-29 Nová forma N-(trans-4-isopropylcyklohexylkarbonyl)-D-fenylalaninu CZ2004997A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000114 WO2003093222A1 (en) 2002-04-29 2002-04-29 Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine

Publications (1)

Publication Number Publication Date
CZ2004997A3 true CZ2004997A3 (cs) 2005-01-12

Family

ID=29287383

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ2004997A CZ2004997A3 (cs) 2002-04-29 2002-04-29 Nová forma N-(trans-4-isopropylcyklohexylkarbonyl)-D-fenylalaninu

Country Status (13)

Country Link
US (1) US7314955B2 (cg-RX-API-DMAC10.html)
EP (1) EP1499586A4 (cg-RX-API-DMAC10.html)
JP (1) JP4137053B2 (cg-RX-API-DMAC10.html)
KR (1) KR20040111490A (cg-RX-API-DMAC10.html)
AU (1) AU2002304281A1 (cg-RX-API-DMAC10.html)
CA (1) CA2481322A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ2004997A3 (cg-RX-API-DMAC10.html)
HR (1) HRP20040920A2 (cg-RX-API-DMAC10.html)
HU (1) HUP0500259A2 (cg-RX-API-DMAC10.html)
IL (1) IL164327A0 (cg-RX-API-DMAC10.html)
MX (1) MXNL04000084A (cg-RX-API-DMAC10.html)
SK (1) SK287644B6 (cg-RX-API-DMAC10.html)
WO (1) WO2003093222A1 (cg-RX-API-DMAC10.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003093222A1 (en) 2002-04-29 2003-11-13 Biocon Limited Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
US6861553B2 (en) 2002-07-03 2005-03-01 Teva Pharmaceuticals Industries Ltd. Process for preparing nateglinide and intermediates thereof
US7358390B2 (en) 2002-07-18 2008-04-15 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7420084B2 (en) * 2002-07-18 2008-09-02 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7148376B2 (en) 2002-07-18 2006-12-12 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7534913B2 (en) 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
WO2004020396A1 (en) * 2002-08-28 2004-03-11 Dr. Reddy's Laboratories Limited Crystalline form of nateglinide and process for preparation thereof
US7449519B2 (en) * 2003-02-18 2008-11-11 Konishi Co., Ltd. Curing resin, method for producing same and curing resin composition
HU227073B1 (hu) * 2003-07-10 2010-06-28 Richter Gedeon Nyrt Eljárás királisan tiszta N-(transz-4-izopropil-ciklohexilkarbonil)-D-fenil-alanin (nateglinid) és kristálymódosulatainak elõállítására, valamint a G-kristálymódosulata
WO2005110395A1 (en) * 2004-05-19 2005-11-24 University Of South Carolina System and device for magnetic drug targeting with magnetic drug carrier particles
GB0413084D0 (en) * 2004-06-11 2004-07-14 Cipla Ltd Process
US20100004334A1 (en) * 2008-07-01 2010-01-07 Mead Johnson Nutrition Company Nutritional Compositions Containing Punicalagins
US11390830B2 (en) 2018-10-05 2022-07-19 The Chemours Company Fc, Llc Compositions comprising 1,2-dichloro-1,2-difluoroethylene for use in cleaning and solvent applications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
US4814684A (en) * 1987-09-30 1989-03-21 Trw Inc. Apparatus for extending the Vout/Vin ratio of a DC-to-DC converter
US5463116A (en) 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
DE69217762T2 (de) 1991-07-30 1997-10-09 Ajinomoto Kk Kristalle von N-(Trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanin und Verfahren zu ihrer Herstellung
WO2003093222A1 (en) 2002-04-29 2003-11-13 Biocon Limited Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine

Also Published As

Publication number Publication date
KR20040111490A (ko) 2004-12-31
SK50052004A3 (sk) 2005-03-04
US7314955B2 (en) 2008-01-01
SK287644B6 (sk) 2011-05-06
MXNL04000084A (es) 2006-02-28
EP1499586A1 (en) 2005-01-26
JP2005523933A (ja) 2005-08-11
IL164327A0 (en) 2005-12-18
HUP0500259A2 (hu) 2005-06-28
WO2003093222A1 (en) 2003-11-13
CA2481322A1 (en) 2003-11-13
US20050165108A1 (en) 2005-07-28
AU2002304281A1 (en) 2003-11-17
HRP20040920A2 (en) 2005-02-28
EP1499586A4 (en) 2006-01-18
JP4137053B2 (ja) 2008-08-20

Similar Documents

Publication Publication Date Title
JP5042215B2 (ja) 網膜疾患を処置するための組成物および方法
CN102030700B (zh) 苯甲酰胺基羧酸类化合物及其制法和药物用途
KR100421580B1 (ko) 치환된벤즈아미딘및이의제조방법
CN102766099B (zh) 具有黄嘌呤氧化酶抑制活性的化合物及其盐、制备方法和用途
AU2024246814A1 (en) Cyclic amine derivative, and composition and use thereof
SK287644B6 (sk) Kryštalický N-(trans)-4-izopropylcyklohexylkarbonyl)-D- fenylalanín vo forme C a spôsob jeho prípravy
SA519402283B1 (ar) مركبات أميد واستخدامها
JP4393376B2 (ja) フェニルシクロヘキシルプロパノールアミン誘導体、その製造法、およびその治療的適用
EP1256341A1 (en) Cancer remedy comprising anthranilic acid derivative as active ingredient
JPS6253966A (ja) 新規ピリジン誘導体
JP7266676B2 (ja) チエノピリドン誘導体のカリウム塩一水和物及びその調製方法
CN103012319B (zh) 瑞格列奈中间体的合成工艺改进
CN103936693A (zh) 2-(3-氰基-4-取代苯基)-4-甲基-1,3-硒唑-5-甲酸及其酯类化合物和制备方法
CN113004355B (zh) 呋喃酮糖苷类化合物、其药物组合物、制备方法及应用
RU2324676C2 (ru) Кристаллический n-(транс-4-изопропилциклогексилкарбонил)-d-фенилаланин формы с для лечения сахарного диабета типа 2 и способ его получения
US4576953A (en) Quinoline derivatives
US20110275834A1 (en) Polymorph of strontium ranelate and a process for its preparation
JPS59199693A (ja) インドリルグリシルセフアロスポリン誘導体
WO2013084150A1 (en) Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof
JP2021513564A5 (cg-RX-API-DMAC10.html)
JPS62286968A (ja) 新規ニコチン酸アミド誘導体
CN113735787A (zh) 萘普生三唑硫酮衍生物及其在制备新冠病毒抑制剂中应用
JPS6134424B2 (cg-RX-API-DMAC10.html)
KR0181215B1 (ko) N-치환 헤테로 화합물 및 이의 제조방법
CN111057069A (zh) 一种环状化合物、其应用及组合物